Læknablaðið - 15.04.2010, Qupperneq 17

FRÆÐIGREINAR
RANNSÓKNIR
24. Brunelli A, Monteverde M, Borri A, Salati M, Marasco RD,
Fianchini A. Predictors of prolonged air leak after pulmonary
lobectomy. Ann Thorac Surg 2004; 77:1205-10.
25. British Thoracic S, Society of Cardiothoracic Surgeons of
Great B, Ireland Working P. BTS guidelines: guidelines on
the selection of patients with lung cancer for surgery. Thorax
2001; 56: 89-108.
26. Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT,
American College of Chest P. Physiologic evaluation of the
patient with lung cancer being considered for resectional
surgery: ACCP evidenced-based clinical practice guidelines
(2nd edition). Chest 2007; 132(3 Suppl):161S-177S.
27. Rostad H, Strand T-E, Naalsund A, Talleraas O, Norstein J.
Lung cancer surgery: the first 60 days.: A population-based
study. Eur J Cardio-Thoracic Surgery 2006; 29: 824-8.
28. Myrdal G, Lamberg K, Lambe M, Stahle E, Wagenius G,
Holmberg L. Regional differences in treatment and outcome
in non-small cell lung cancer: a population-based study
(Sweden). Lung Cancer 2009; 63:16-22.
29. Spiro SG, Gould MK, Colice GL, American College of Chest P.
Initial evaluation of the patient with lung cancer: symptoms,
signs, laboratory tests, and paraneoplastic syndromes: ACCP
evidenced-based clinical practice guidelines (2nd edition).
Chest 2007; 132(3 Suppl):149S-160S.
Postoperative complications following lobectomy for lung cancer in lceland
during 1999-2008
Objective: Non small cell lung cancer (NSCLC) is the
second most common cancer in lceland. We studied the
indications and surgical outcome of lobectomy for NSCLC
in lceland.
Materials and methods: 213 consecutive patients
underwent lobectomy for NSCLC between 1999 and
2008. Data on indications, histology, TNM-stage and
complications were analysed, and logistic regression used
to assess outcome predictors.
Results: The majority of patients (60%) were referred
because of symptoms, whereas 40% were asymptomatic.
Adenocarcinoma (62%) and squamous cell carcinoma
(29%) were the most frequent histological types. Operative
staging showed that 59.6% of cases were stage 1,17.8%
were stage II, 7% were stage IIIA and 14.6% were stage
IIIB or IV. Mediastinoscopy was performed in 13.6% of
cases. Mean operative time was 128 min., operative
bleeding 580 ml and median hospital stay 10 days. Sixteen
patients (7.5%) had major complications and 36 (17.5%)
had minor complications, such as atrial fibrillation and
pneumonia. Twelve patients required reoperation, most
often due to bleeding, but two had empyema and one
had a bronchopleural fistula. Older patients with high ASA
scores and extensive smoking history were at increased
risk for complications. No patient died within 30 days of
surgery whereas two (0,9%) died within 90 days of surgery.
Conclusions: The results of lobectomy for NSCLC in
lceland are excellent in relation to operative mortality and
short term complications.
Skuladottir R, Oskarsdottir GN, Isaksson HJ, Jonsson J, Thorsteinsson H, Gudbjartsson T.
Postoperative complications following lobectomy for lung cancer in lceland during 1999-2008. Icel Med J 2010; 96:243-9.
Key words: Lung cancer, lobectomy, surgery, indications, complications, operative mortality.
Correspondence: Tómas Guðbjartsson, tomasgud@landspitali.is
>
DC
<
2
2
Z>
w
X
w
_1
u
z
LU
Barst: 4. október 2009, - samþykkt til birtingar: 25. janúar 2010
Hagsmunatengsl: Engin
LÆKNAblaðið 2010/96 249